Tumor necrosis factor-alpha, Interleukin-6, Interleukin-8, Chemokine (C-X-C motif) ligand 1, Macrophage inflammatory protein 2, and Mucin 5AC (TNF-α, IL-6, IL-8, CXCL-1, MIP-2, MUC5AC)

This target entry represents a collection of distinct pro-inflammatory mediators and a mucin protein rather than a single therapeutic target. Tumor necrosis factor-alpha (TNF-α) and Interleukin-6 (IL-6) are key cytokines that drive systemic and local inflammation by activating various signaling pathways, including NF-κB and JAK/STAT (UniProt P01375, P05231). Interleukin-8 (IL-8), Chemokine (C-X-C motif) ligand 1 (CXCL-1), and Macrophage inflammatory protein 2 (MIP-2) are chemokines primarily responsible for the recruitment and activation of neutrophils to sites of injury or infection (PubMed: 12117604). Mucin 5AC (MUC5AC) is a major gel-forming glycoprotein in the airway mucus, often upregulated by these inflammatory signals, leading to mucus hypersecretion in respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) (PubMed: 25243877). While individual components like TNF-α and IL-6 are validated drug targets with several approved monoclonal antibodies, this specific grouping is typically used as a panel of biomarkers to assess the inflammatory status or the efficacy of anti-inflammatory treatments in preclinical and clinical research (StatPearls: NBK470413). Therapeutic strategies targeting these molecules aim to alleviate chronic inflammation and reduce mucus-mediated airway obstruction. For instance, TNF-alpha inhibitors like infliximab and IL-6 inhibitors like tocilizumab are widely used in autoimmune conditions, while IL-8 and MUC5AC remain active areas of research for respiratory-specific therapies. The inclusion of MIP-2 suggests a focus on murine models, as it is the functional mouse homolog for human neutrophil-attracting chemokines. Overall, this set of molecules characterizes the complex interplay between immune cell recruitment and epithelial dysfunction in inflammatory pathologies.

Other names

TNF-alphaIL-6IL-8CXCL1MIP-2MUC5ACCXCL8GRO-alphaCXCL2CachectinB-cell stimulatory factor 2

Neutralization of pro-inflammatory cytokines and chemokines to inhibit leukocyte recruitment and reduce mucus hypersecretion.